— Know what they know.
Not Investment Advice

SIBN

SI-BONE, Inc.
1W: +0.5% 1M: -15.6% 3M: -38.0% YTD: -34.8% 1Y: -12.9% 3Y: -33.5% 5Y: -61.3%
$12.91
-0.26 (-1.97%)
After Hours: $13.95 (+1.04, +8.09%)
NASDAQ · Healthcare · Medical - Devices · $570.2M · Alpha Radar Strong Sell · Power 32
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$570.2M
52W Range12.5-21.89
Volume464,357
Avg Volume563,327
Beta0.69
Dividend
Analyst Ratings
9 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOLaura A. Francis
Employees349
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-10-17
471 El Camino Real
Santa Clara, CA 95050
US
408 207 0700
About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Recent Insider Trades

NameTypeSharesPriceDate
Nishimura Mika S-Sale 4,100 $13.83 2026-03-12
PISETSKY MICHAEL A. S-Sale 2,556 $15.39 2026-02-17
PISETSKY MICHAEL A. S-Sale 3,296 $15.41 2026-02-17
PISETSKY MICHAEL A. S-Sale 1,481 $15.32 2026-02-17
PISETSKY MICHAEL A. S-Sale 11,569 $15.34 2026-02-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms